LINDSEY ANDRADE: Open Payments
NPI 1447776505 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,697 in 73 payments from 20 companies in 2025. Trend: 2023 $501 · 2024 $1,074 · 2025 $1,697
Food & beverage: $1,497Education: $200
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $227 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $212 |
| ABBVIE INC. | 10 | $200 |
| Janssen Biotech, Inc. | 5 | $183 |
| UCB, Inc. | 10 | $164 |
| GENZYME CORPORATION | 5 | $136 |
| Lilly USA, LLC | 4 | $96 |
| LEO Pharma Inc. | 3 | $71 |
| Novartis Pharmaceuticals Corporation | 2 | $64 |
| Incyte Corporation | 3 | $64 |
Products named: DUPIXENT, TREMFYA, Bimzelx, SKYRIZI, TALTZ, ILUMYA, RINVOQ, Rhapsido.
Industry payments across AZ — which companies pay providers there.
